World G7 to donate 1 billion COVID-19 vaccine doses to poorer countries
Fact check: Post misleads on effectiveness of J&J COVID-19 vaccine in older adults
A post online from anti-vaccination group Physicians for Informed Consent claims J&J COVID-19 vaccine ineffective in older adults. This is false.Use of the one-dose shot was paused for several weeks but lifted on April 23 after both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control found the vaccine was overall safe and effective.
By Kate Holton
CARBIS BAY, England (Reuters) - British Prime Minister Boris Johnson expects the Group of Seven to agree to donate 1 billion COVID-19 vaccine doses to poorer countries during its summit starting on Friday, and help innoculate the world by the end of next year.
Just hours after U.S. President Joe Biden vowed to supercharge the battle against the coronavirus with a donation of 500 million Pfizer shots, Johnson said Britain would give at least 100 million surplus vaccines to the poorest nations.
Teens and adults miss 26 million doses of CDC-recommended vaccines during the COVID-19 pandemic, study finds
Researchers found teens may have missed more than 8 million vaccine doses and adults may have missed over 17 million doses.The study, commissioned by GlaxoSmithKline (GSK) and conducted by Avalere Health, analyzed vaccine claims from January through November 2020 and compared them to the same timeframe in 2019.
Johnson has already called on G7 leaders to commit to vaccinate the entire world by the end of 2022 and the group is expected to pledge 1 billion doses during its three-day summit in the English seaside resort of Carbis Bay.
Some campaign groups condemned the plan as a drop in the ocean, with Oxfam estimating that nearly 4 billion people will depend on COVAX for vaccines, the programme that distributes COVID-19 shots to low and middle income countries.
"As a result of the success of the UK's vaccine programme we are now in a position to share some of our surplus doses with those who need them," Johnson will say on Friday, according to excerpts of the announcement released by his office.
"In doing so we will take a massive step towards beating this pandemic for good."
Going to waste? Hundreds of thousands of doses of Johnson & Johnson COVID-19 vaccine will expire this month.
Almost 52% of people in the United States have received at least one COVID-19 shot but vaccination rates are falling to new lows in many states."When we had more demand than the supply could meet, expiration dates weren't a problem. Vaccine was being used up as fast as it came in the door," said Dr. Kelly Moore, deputy director of the Immunization Action Coalition.
COVID-19 has killed around 3.9 million people and ripped through the global economy, with infections reported in more than 210 countries and territories since the first cases were identified in China in December 2019.
While scientists have brought vaccines to market at breakneck speeds - Britain has given a first dose to 77% of its adult population and the United States 64% - they say the pandemic will only end once all countries have been vaccinated.
With a global population nearing 8 billion and most people needing two doses, if not booster shots to tackle variants as well, campaigners said the commitments marked a start but world leaders needed to go much further, and much faster.
"The G7's aim to provide 1 billion doses should be seen as an absolute minimum, and the timeframe needs to speed up," said Lis Wallace at anti-poverty campaign group ONE.
"We're in a race with this virus and the longer it's in the lead the greater the risk of new, more dangerous variants undermining global progress."
'Pandemic misery' index finds hardship hit most people, but Black and Latino Americans suffered most. Latest COVID-19 updates.
An index of “pandemic misery” released this week found that 80% of people involved in the survey experienced hardships in the past year.The index looked at nine indicators to determine “pandemic misery”: financial insecurity, food insecurity, symptoms of moderate or severe psychological distress, symptoms of high stress, job loss since March 2020, experience of COVID-19-based discrimination, missing a housing payment, being put in isolation or quarantine, and a COVID-19 diagnosis or perceived COVID-19 infection.
Of the 100 million British shots, 80 million will go to the COVAX programme led by the World Health Organization (WHO) and the rest will be shared bilaterally with countries in need.
Johnson echoed Biden in calling on his fellow leaders to make similar pledges and for pharmaceutical companies to adopt the Oxford-AstraZeneca model of providing vaccines at cost for the duration of the pandemic.
Leaving poorer countries to deal with the pandemic alone risks allowing the virus to further mutate and evade vaccines. Charities have also said that logistical support will be needed to help administer large numbers of vaccines in poorer countries.
The British doses will be drawn from the stock it has already procured for its domestic programme, and will come from suppliers Oxford-AstraZeneca, Pfizer-BioNTech, Janssen, Moderna and others.
(Reporting by Kate Holton; editing by Guy Faulconbridge and Grant McCool)
Who benefits? US debates fairest way to share spare vaccine .
In April, the Biden administration announced plans to share millions of COVID-19 vaccine doses with the world by the end of June. Five weeks later, nations around the globe are still waiting — with growing impatience — to learn where the vaccines will go and how they will be distributed. © Getty Los Angeles, CA - April 15: Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with Pfizer COVID-19 vaccine before giving it to people on the first day that people ages 16 and up can receive the vaccine at Kedren Health on Thursday, April 15, 2021 in Los Angeles, CA.